Sodium thiosulphate treatment of uraemic tumoral calcinosis

Rheumatology (United Kingdom)

Volumn 53, Issue 3, 2014, Pages 547-551

  Malbos, Stéphanie ^a   Urena Torres, Pablo ^b   Cohen Solal, Martine ^a,c,d   Trout, Hervé ^d   Lioté, Frédéric ^a,c,d   Bardin, Thomas ^a,c,d   Ea, Hang Korng ^a,c,d  

^a CENTRE VIGGO PETERSEN   (France)

^b Clinique du Landy   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Apatite; Calcification; Dialysis; Renal failure; Sodium thiosulphate; Tumoral calcinosis

Indexed keywords

APATITE; CALCIFICATION; DIALYSIS; RENAL FAILURE; SODIUM THIOSULPHATE; TUMORAL CALCINOSIS;

AGED; CALCINOSIS; COMORBIDITY; FEMALE; HUMANS; HYPERTENSION; INCIDENCE; KIDNEY DISEASES; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NAUSEA; RENAL DIALYSIS; RETROSPECTIVE STUDIES; THIOSULFATES; TREATMENT OUTCOME; UREMIA; VOMITING;

EID: 84894313886     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ket388     Document Type: Article

References (16)

1. Frishberg Y, Topaz O, Bergman R et al. Identification of a recurrent mutation in GALNT3 demonstrates that hyperostosis-hyperphosphatemia syndrome and familial tumoral calcinosis are allelic disorders. J Mol Med 2005;83:33-8.
2. Ichikawa S, Sorenson AH, Austin AM et al. Ablation of the Galnt3 gene leads to low-circulating intact fibroblast growth factor 23 (Fgf23) concentrations and hyperphosphatemia despite increased Fgf23 expression. Endocrinology 2009;150:2543-50.
3. Olsen KM, Chew FS. Tumoral calcinosis: pearls, polemics, and alternative possibilities. Radiographics 2006;26:871-85.
4. Zins B, Zingraff J, Basile C et al. Tumoral calcifications in hemodialysis patients: possible role of aluminum intoxication. Nephron 1992;60:260-7.
5. Floege J, Ketteler M. Vascular calcification in patients with end-stage renal disease. Nephrol Dial Transplant 2004;19(Suppl 5):V59-66.
6. Lipsker D, Chosidow O, Martinez F et al. Low-calcium dialysis in calciphylaxis. Arch Dermatol 1997;133:798-9.
7. Fernandez E, Montoliu J. Successful treatment of massive uraemic tumoral calcinosis with daily haemodialysis and very low calcium dialysate. Nephrol Dial Transplant 1994;9:1207-9.
8. McGregor D, Burn J, Lynn K et al. Rapid resolution of tumoral calcinosis after renal transplantation. Clin Nephrol 1999;51:54-8.
9. Yatzidis H, Agroyannis B. Sodium thiosulfate treatment of soft-tissue calcifications in patients with end-stage renal disease. Perit Dial Bull 1987;7:250-2.
10. Kyriakopoulos G, Kontogianni K. Sodium thiosulfate treatment of tumoral calcinosis in patients with end-stage renal disease. Ren Fail 1990;12:213-9.
11. Papadakis JT, Patrikarea A, Digenis GE et al. Sodium thiosulfate in the treatment of tumoral calcifications in a hemodialysis patient without hyperparathyroidism. Nephron 1996;72:308-12.
12. Ratsimbazafy V, Bahans C, Guigonis V. Dramatic diminution of a large calcification treated with topical sodium thiosulfate. Arthritis Rheum 2012;64:3826.
13. Pasch A, Schaffner T, Huynh-Do U et al. Sodium thiosulfate prevents vascular calcifications in uremic rats. Kidney Int 2008;74:1444-53.
14. O'Neill WC, Hardcastle KI. The chemistry of thiosulfate and vascular calcification. Nephrol Dial Transplant 2012;27:521-6.
15. Asplin JR, Donahue SE, Lindeman C et al. Thiosulfate reduces calcium phosphate nephrolithiasis. J Am Soc Nephrol 2009;20:1246-53.
16. Hayden MR, Tyagi SC, Kolb L et al. Vascular ossificationcalcification in metabolic syndrome, type 2 diabetes mellitus, chronic kidney disease, and calciphylaxis-calcific uremic arteriolopathy: the emerging role of sodium thiosulfate. Cardiovasc Diabetol 2005;4:4.